.
MergerLinks Header Logo

New Deal


Announced

Completed

Invaio Sciences completed the acquisition of Peptyde Bio.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

United States

peptides developer

agtech

Machinery: Agricultural

Acquisition

Private

Majority

Domestic

Completed

Friendly

Single Bidder

Synopsis

Edit

Invaio Sciences, a bio platform company accelerating the leap to nature-positive agriculture, completed the acquisition of Peptyde Bio, a company that discovers, designs and characterizes novel peptides for use in agriculture. Financial terms were not disclosed. “This acquisition adds Peptyde Bio’s portfolio of confirmed peptide lead candidates for use in crop protection to our existing pipeline. When combined with our innovative biological delivery systems, we are uniquely positioned to offer growers more natural, efficient and effective solutions to protect their crops. It’s a truly exciting time for Invaio and the industry as we accelerate the leap to more nature-positive solutions for farmers,” Ignacio Martinez, Invaio Sciences CEO.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US